Dr Robert Nordgren | Head Of Research And Development
Curtiss Healthcare

Dr Robert Nordgren, Head Of Research And Development, Curtiss Healthcare

Bob has over 30 years’ experience in the field of veterinary vaccine and biotherapeutic R&D with leading international animal health companies, with bench to leadership roles in Solvay, Boehringer Ingelheim and Merial. Teams under Bob’s leadership have developed and launched vaccines and therapeutics in all major species, including many industry firsts or leading products in their field. Bob is now leading the R&D efforts for Curtiss Healthcare Inc, which is dedicated to creating and licensing unique products intended to improve the safety and quality of the world’s protein supply, as well as supporting The YieldLab, an investment/incubator identifying start-up companies supporting sustainable agriculture.


April 17 Day 3 - 10 Co-conferences & Plenary @ 09:40

Developing vaccines against bacterial pathogens in animal species and humans using a salmonella vaccine vector platform

last published: 11/Apr/19 16:05 GMT

back to speakers

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington


To Sponsor Or Exhibit

Marc Rhys-Evans
+44 20 7827 5945




To Register

Tayyab Abbasi
+44 20 7092 1210




Press Relations

Karina Kusova
+44 20 7092 1071